- Global Pharma News & Resources

Global Shingles Vaccine Market Size, Top Countries Data Industry Share, Revenue, Latest Trends, Business Improving Strategies, CAGR Status, Growth Opportunities and Forecast To 2027

The global and regional Shingles Vaccine Market report with a detailed analysis of the overall growth outlook for the Industry. In addition, it sheds light on the comprehensive competitive environment of the global Shingles Vaccine market. The report also provides an overview of the dashboards of leading companies, including successful marketing strategies, market contributions, and recent developments in both historical and current contexts.

Major companies involved in the global shingles vaccine market are: Merck, GlaxoSmithKline

Ask for Sample Copy of Shingles Vaccine Market report @

Overview of Shingles Vaccine

A shingles vaccine is an injectable vaccine that reduces the risk of developing shingles, a dangerous disease caused by activation of the herpes simplex virus, which is responsible for chickenpox. Shingles usually manifest with a severe, painful rash that covers the entire body, including the face, neck, and eyes. Shingles often lead to long-term complications, such as nervous breakdown, muscle weakness, and permanent vision loss. Shingles vaccine prevents chickenpox in about 90% of individuals who receive the recommended dosage. The global shingles vaccine market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global shingles vaccine market is expected to witness significant growth during the forecast period, owing to rising approval and launch of advanced shingles vaccines.

COVID-19 Impact

Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Shingles Vaccine market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
To know how the impact of COVID-19 is addressed in Shingles Vaccine Market. Get a sample of the report @

Market Drivers

By Type: Zostavax, Shingrix

By Application: Under 50 Years Old, 50-60 Years Old, 60-70 Years Old, Above 70 Years Old,

Rising cases of shingles is expected to drive growth of the global shingles vaccine market during the forecast period. According to the Centers Disease Control and Prevention (CDC), around 1 out of 3 people in the U.S. are expected to develop shingles in their lifetime, while around 1 million people get shingles each year in the U.S. This, in turn, has increased the adoption of shingles vaccine is expected to drive growth of the global shingles vaccine market during the forecast period. Furthermore, rising approval and launch of advanced shingles vaccines is expected to propel the global shingles vaccine market growth over the forecast period.

If you have any query related to Shingles Vaccine market report, you can ask to our expert @

Points Covered in the Report

  • The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
  • The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
  • The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
  • Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
  • The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Regional Insights

Region-Wise Classification of the Market: North America, South America, Europe, Asia-Pacific, Africa, Middle East

Among regions, North America is expected to witness significant growth in the global shingles vaccine market during the forecast period. This is owing to high prevalence of the disease across the U.S. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to improving healthcare infrastructure across the region.

Buy this Report @

About WMR                                                                                        

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provides our diverse range of clients from across all industries with vital decision-making insights to plan and align their market strategies in line with current market trends.

Contact Us:    

Worldwide Market Reports,

Tel: U.S. +1-415-871-0703 / U.K. +44-203-289-4040 / Japan +81-50-5539-1737


Editor Details

  • Company:
    • CDN Newswire
Last Updated: 05-Oct-2021